Corporate Team 2022

Our InsuLife team brings a powerful combination of proven commercial, strategic and scientific capabilities.

Åge Nærdal

Co-Founder
Chief Executive Officer
View Profile >

Christian H. Theiste

Co-Founder
Chief Operating Officer
View Profile >

Olav Flaten

Chief Medical Officer
View Profile >

Henrik Bruun Andersen

Chief Financial Officer
View Profile >

Karen D. Quinn, Ph.D.

Head of Regulatory Affairs
View Profile >

Steven Akhtar

Operations Associate
View Profile >
InsuLife is a Norwegian company aiming at bringing the unparalleled developmental INS-2301 skin-applied insulin to market.
Learn More
© Copyright 2024 - InsuLife AS, All Rights Reserved
cross